Search Results for pharmaceutical companies

Showing 1 – 4

340B: Health System Execs Push Back on Narrowing of Drug Discount Program By Zachary Brennan - Published 11 October 2017

The House Energy & Commerce's subcommittee on Oversight and Investigations on Wednesday discussed the federal 340B drug discount program, which provides participating hospitals and other medical providers deep discounts on outpatient drugs. 

Categories: News, US, Drugs, Government affairs, Reimbursement

Tags: 340B program, drug discounts, pharmaceutical companies

EMA Plots New Ways to Help Small and Medium-Sized Pharma Firms By Zachary Brennan - Published 31 May 2017

The European Medicines Agency (EMA) on Wednesday published an action plan for the next three years to help small and medium-sized pharmaceutical companies.

Categories: News, Europe, EMA, Biologics and biotechnology, Drugs, Due Diligence, Government affairs, Medical Devices, Regulatory intelligence, Regulatory strategy

Tags: small- and medium-sized pharmaceutical companies, EMA on SMEs

EMA to Pharma Companies: Prepare for UK to EU Shift By Zachary Brennan - Published 02 May 2017

Setting the stage for a likely exodus from the UK for pharmaceutical manufacturers and staff, the European Medicines Agency (EMA) on Tuesday notified marketing authorization holders (MAHs) that for centrally authorized products, EU law requires them to be established in the EU or European Economic Area, which includes Iceland, Liechtenstein and Norway.

Categories: News, Europe, EC, EMA, MHRA, Biologics and biotechnology, Compliance, Drugs, Regulatory intelligence, Regulatory strategy

Tags: Brexit, pharmaceutical companies in UK, MAHs in UK

UK, French Regulators Call Out Two Noncompliant Indian Pharma Sites By Zachary Brennan - Published 04 April 2016

UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) and France’s ANSM (National Agency for Medicines and Health Products Safety) have sent notices of noncompliance to two Indian pharmaceutical companies that restrict the dissemination of their products in Europe.

Categories: News, India, Europe, EC, MHRA, Drugs, Due Diligence, Ethics, Government affairs, Manufacturing, Postmarket surveillance, Product withdrawl and retirement

Tags: MHRA, ANSM, Indian pharmaceutical manufacturing, noncompliant pharmaceutical companies